Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS

Quality of Life Research

Volumn 21, Issue 4, 2012, Pages 613-623

  Tran, Bach Xuan ^a,b   Ohinmaa, Arto ^a,c   Duong, Anh Thuy ^d   Do, Nhan Thi ^d   Nguyen, Long Thanh ^d   Nguyen, Quoc Cuong ^e   Mills, Steve ^e   Jacobs, Philip ^a,c   Houston, Stan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d MINISTRY OF HEALTH   (Viet Nam)

^e FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Drug use; HIV; Methadone; Quality of life; Vietnam; WHOQOL BREF

Indexed keywords

METHADONE;

ADDICTION; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; VIET NAM;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LONGITUDINAL STUDIES; MALE; METHADONE; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS; VIETNAM; YOUNG ADULT;

EID: 84863609163     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-9963-y     Document Type: Article

References (48)

1. Jain, M. K. (2009). Mortality in patients coinfected with hepatitis B virus and HIV: Could antiretroviral therapy make a difference? Clinical Infectious Diseases, 48(12), 1772-1774.
2. Castelnuovo, B., et al. (2009). Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clinical Infectious Diseases, 49(6), 965-972.
3. Zwahlen, M., et al. (2009). Mortality of HIV-infected patients starting potent antiretroviral therapy: Comparison with the general population in nine industrialized countries. International Journal of Epidemiology.
4. Spire, B., Lucas, G. M., & Carrieri, M. P. (2007). Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). International Journal of Drug Policy, 18(4), 262-270. (Pubitemid 47126278)
5. UNAIDS. (2008). Report on the global AIDS epidemic. UNA-IDS/08.25E/ JC1510E.
6. The Commission on Aids in Asia. (2008). Redefining AIDS in Asia: Crafting an effective response. Oxford: Oxford University Press, 258 p. Available at http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2008/ 20080326-report-commission-aids-en.pdf.
7. Vietnam Administration of HIV/AIDS Control. (2010). Report on the current situation of HIV infection in 2009. Hanoi: Vietnam. http://www.vaac.gov. vn/Desktop. aspx/Noi-dung/Tinh-hinh-dich/Tinh-hinh-dich-nhiem-HIVAIDS-toan-quoc- nam-2009.
8. Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. Lancet, 376(9738), 355-366.
9. Bergenstrom, A. M., & Abdul-Quader, A. S. (2010). Injection drug use, HIV and the current response in selected low-income and middle-income countries. AIDS, 24(Suppl 3), S20-S29.
10. Ministry of Health (2010). V., Report on current situation of the HIV epidemics in Vietnam, from January 1, 2009 to December 12, 2009.
11. Ministry of Health (2008). HIV/AIDS estimates and projections 2008-2012. Bucharest: Medical Publishing House.
12. Ministry of Health (2008). National strategy on HIV/AIDS prevention and control towards 2010. Bucharest: Medical Publishing House.
13. Ministry of Health (2007). National HIV AIDS care and treatment guidelines. Hanoi, Vietnam: Medical Publishing House.
14. Ministry of Health. (2009). The annual review of HIV/AIDS control and prevention in 2008 and action plan in 2009, Hanoi.
15. Palepu, A., et al. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction, 99(3), 361-368. (Pubitemid 38333828)
16. Palepu, A., et al. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 84(2), 188-194. (Pubitemid 44119095)
17. Roux, P., et al. (2009). Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49(9), 1433-1440.
18. Mannheimer, S. B., et al. (2005). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 17(1), 10-22. (Pubitemid 40175528)
19. Winklbaur, B., et al. (2008). Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment. European Addiction Research, 14(2), 99-105. (Pubitemid 351365642)
20. Ministry of Health (2006). Results from the HIV/STI intergrated biological and behavioral surveillance (IBBS) in Vietnam 2005-2006. Hanoi, Vietnam: Medical Publishing House.
21. Ministry of Labor, Invalid and Social Affair (2001). Survey report on drug users in 2001. Hanoi: Vietnam.
22. Bach Xuan Tran, et al. (2010). Modeling the cost-effectiveness of methadone maintenance treatment program on HIV prevention, care and treatment. Presentation at the 3rd Vietnam National Congress on HIV/AIDS, Hanoi, Vietnam.
23. Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004). The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299-310. (Pubitemid 38392258)
24. WHO (2001). Translation methodology. WHO/MNH/PSF/95.2, pp. 9-10.
25. Linden, A., & Adams, J. L. (2010). Evaluating health management programmes over time: Application of propensity scorebased weighting to longitudinal data. Journal of Evaluation in Clinical Practice, 16(1), 180-185.
26. Lu, B. (2005). Propensity score matching with time-dependent covariates. Biometrics, 61(3), 721-728.
27. Hosmer, D. W., & Lemeshow, S. (2000). Applied logistic regression (2nd ed.). New York: Wiley. ISBN 0-471-35632-8.
28. Rabe-Hesketh, S., & Skrondal, A. (2005). Multilevel and longitudinal modeling using Stata. College Station, TX: Stata Press Publication, StataCorp LP.
29. Hanley, J. A., et al. (2003). Statistical analysis of correlated data using generalized estimating equations: An orientation. American Journal of Epidemiology, 157(4), 364-375. (Pubitemid 36196757)
30. Raffa, J. D., et al. (2007). The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug and Alcohol Dependence, 89(2-3), 306-309. (Pubitemid 46778790)
31. Sakthong, P., et al. (2007). Psychometric properties of WHO-QOL-BREF-THAI in patients with HIV/AIDS. Journal of the Medical Association of Thailand, 90(11), 2449-2460. (Pubitemid 350256452)
32. Ohaeri, J. U., et al. (2007). Confirmatory factor analytical study of the WHOQOL-Bref: Experience with Sudanese general population and psychiatric samples. BMC Medical Research Methodology, 7, 37.
33. Trompenaars, F. J., et al. (2005). Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. Quality of Life Research, 14(1), 151-160. (Pubitemid 40249089)
34. Saddki, N., et al. (2009). Validity and reliability of the Malay version of WHOQOL-HIV BREF in patients with HIV infection. AIDS Care, 21(10), 1271-1278.
35. Grice, J. W. (2001). Computing and evaluating factor scores. Psychological Methods, 6(4), 430-450. (Pubitemid 33599069)
36. Grice, J. W. (2001). A comparison of factor scores under conditions of factor obliquity. Psychological Methods, 6(1), 67-83.
37. Hammett, T. M., et al. (2008). 'Social evils' and harm reduction: The evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction, 103(1), 137-145. (Pubitemid 350233419)
38. Clarke, S., et al. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33-37. (Pubitemid 37161534)
39. Xiao, L., et al. (2010). Quality of life of outpatients in methadone maintenance treatment clinics. Journal of Acquired Immune Deficiency Syndromes, 53(Suppl 1), S116-S120.
40. UNDP (2010). Socioeconomic impact of HIV/AIDS on poverty and household vulnerability in Vietnam, Hanoi.
41. Lawrinson, P., et al. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103(9), 1484-1492.
42. Li, X., et al. (2009). Consequences of drug abuse and HIV/AIDS in China: Recommendations for integrated care of HIV-infected drug users. AIDS Patient Care STDS, 23(10), 877-884.
43. Wood, E., et al. (2005). Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users. AIDS, 19(8), 837-839. (Pubitemid 40834758)
44. Tran B. X., et al. (2011). Determinants of health-related quality of life in adults with HIV in Vietnam. AIDS Care. doi:10.1080/09540121.2011.555749.
45. Roux, P., et al. (2008). The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study. Addiction, 103(11), 1828-1836.
46. Berg, K. M., et al. (2009). Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemporary Clinical Trials, 30(5), 481-489.
47. Lucas, G. M., et al. (2006). Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases, 42(11), 1628-1635.
48. Clarke, S., et al. (2002). Directly observed antiretroviral therapy for injection drug users with HIV infection. AIDS Read, 12(7), 305-307, 312-316.